Clinical Immunology Communications (Jun 2024)

Somatic variant profiling of a thymoma in Good syndrome

  • Kae Takagi,
  • Yui Namikawa,
  • Masayuki Nagasawa,
  • Masahiro Mae,
  • Yoshihiko Watanabe,
  • Kohsuke Imai,
  • Hirokazu Kanegane,
  • Tomohiro Morio,
  • Masatoshi Takagi

Journal volume & issue
Vol. 5
pp. 12 – 19

Abstract

Read online

Good syndrome (GS) is a combined immunodeficiency that is associated with thymomas. The cause of the reduction in B-cells in patients with GS may be multifactorial and may include dysregulated T-cell responses. It has been proposed that tumorigenesis in a normal thymus alters thymic epithelial cell function, which leads to attenuated elimination of T-cells autoreactive to B-cells. Although the comprehensive genetic analysis of thymoma has been performed and reported in many articles, the comprehensive genetic analysis specified for GS-related thymoma has not been reported. Herein, we report comprehensive genetic analysis of a thymoma taken from a patient with GS. Oncogenesis-associated genes that may contribute to thymoma development were detected. Additionally, alteration of VCAM1, which is required in the interaction between T-cells and thymic epithelial cells, was observed. Aberrantly expressed VCAM1 in thymic epithelial cells may decrease the efficacy of negative of selection autoreactive T-cells and contribute to autoimmunity to B-cells.

Keywords